About this trial
The goal of this clinical trial is to investigate whether the use of bronchial blocker could reduce the incidence of postoperative vocal cord palsy than the use of double-lumen endobronchial tube in robot-assisted esophagectomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adults aged 19 or older
American Society of Anesthesiologists physical status I - III
Elective robot-assisted esophagectomy
Any clinical stage of esophageal cancer
Disqualifiers
Patients who diagnosed vocal cord palsy or damage before surgery
Patients who need specific airway device due to airway problem
History of thoracic surgery
Emergency surgery
Trial design
Parallel
Treatments tested in this trial
bronchial blocker
DeviceLung isolation for robot-assisted esophagectomy will be performed using bronchial blocker in this group.
double-lumen endobronchial tube
DeviceLung isolation for robot-assisted esophagectomy will be performed using double-lumen endobronchial tube in this group.
Treatment groups
Trial outcomes
Primary outcomes
Postoperative vocal cord palsy
On postoperative day 7, ENT doctor will performed the laryngoscopy exam to check the presence of vocal cord palsy.
Secondary outcomes
Number of resected recurrent laryngeal nerve lymph nodes
Number of successfully resected recurrent laryngeal nerve lymph nodes will be counted at the end of surgery
Quality of one lung ventilation
during one lung ventilation, anesthesiologists will evaluate the degree (excellent, fair, poor) of lung collapse.
Surgical difficulty reported by surgeon
Surgeon will report the surgical difficulty (easy, moderate, difficult).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.